Lisata Therapeutics, Inc.

LSTA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$20-$21-$54-$27
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$2$3$2
Change in WC-$1-$0-$1$1
Other Non-Cash-$0-$1$31$3
Operating Cash Flow-$19-$20-$21-$22
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions-$0$0-$3$0
Inv. Purchases-$56-$98-$90-$180
Inv. Sales/Matur.$69$109$122$125
Other Inv. Act.$0$0$0-$0
Investing Cash Flow$13$10$29-$55
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$86
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0-$0-$0
Financing Cash Flow-$0$0-$0$85
Forex Effect-$0-$0-$0$0
Net Chg. in Cash-$6-$10$8$8
Supplemental Information
Beg. Cash$23$32$25$17
End Cash$16$23$32$25
Free Cash Flow-$19-$20-$21-$22